Risk factor
Very high price volatility
Profitability factor
Strong growth
About
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. It operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes third party products to the diagnostic imaging sector. The...
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks.
Target Price
The average target price of CYC.AX is 1.5 and suggests 31% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
Buy
Sell